Recent Investment Analysts’ Ratings Changes for Addus HomeCare (ADUS)

Addus HomeCare (NASDAQ: ADUS) has recently received a number of price target changes and ratings updates:

• 9/28/2026 – Addus HomeCare was given a new $137.00 price target by Raymond James Financial, Inc..
• 9/24/2026 – Addus HomeCare was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 9/14/2026 – Addus HomeCare was downgraded by Citigroup Inc. from “market outperform” to “neutral”.
• 9/14/2026 – Addus HomeCare was given a new $125.00 price target by Raymond James Financial, Inc..
• 9/14/2026 – Addus HomeCare had its “neutral” rating reaffirmed by Bank of America Corporation. They now have a $125.00 price target on the stock, down from $140.00.
• 8/5/2026 – Addus HomeCare had its price target raised by Royal Bank Of Canada from $130.00 to $134.00. They now have an “outperform” rating on the stock.

Addus HomeCare Corporation is a provider of home-based health care and support services for older adults, people with disabilities and other individuals who require assistance at home. The company’s services are designed to help clients maintain independence and avoid or delay institutional care.

Addus operates through three primary service lines: personal care, home health and hospice. Personal care services include assistance with daily activities such as bathing, dressing, meal preparation and mobility.